The cyclic nucleotide phosphodiesterase inhibitor IBMX, which indirectly enhances intracellular levels of cAMP through inhibiting its degradation30, similarly enhanced BC formation in HepaRG cells, but also in a weaker manner than FSK (Supplementary Fig. S4). The gene discussed is PDE3B; the disease is breast cancer.